This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "20181019 PLA call"

From HL7Wiki
Jump to navigation Jump to search
Line 78: Line 78:
 
Agenda review
 
Agenda review
 
*Notes of [[20181005_PLA_WGM]] review
 
*Notes of [[20181005_PLA_WGM]] review
 +
*Action items
 +
**Need to look at what we’re calling things vs. what they are. Need to figure out terms that disambiguate what we’ve created. Encourage the organization to clearly delineate what we mean by these names.
 +
**MK will pull up the meeting minutes from the steering divisions to see what they’ve been doing. If steering divisions went away, who would be responsible for those things.
 
*Discussion Topics
 
*Discussion Topics
 
**Management group health metrics
 
**Management group health metrics

Revision as of 15:34, 19 October 2018

return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program

HL7 PLA Call Minutes

Location: Phone: +1 770-657-9270, Participant Code: 985371,
https://global.gotomeeting.com/join/177894709

Date: 2018-10-19
Time: 11:30 AM
Facilitator Mary Kay/ Austin Note taker(s) Anne
Attendee Name


Calvin Beebe
Lorraine Constable
Jean Duteau,
Tony Julian
Paul Knapp
Austin Kreisler,
Mary Kay McDaniel
Brian Pech
Wayne Kubick
John Roberts
Andy Stechishin
no quorum definition

Agenda

Agenda review

  • Notes of 20181005_PLA_WGM review
  • Action items
    • Need to look at what we’re calling things vs. what they are. Need to figure out terms that disambiguate what we’ve created. Encourage the organization to clearly delineate what we mean by these names.
    • MK will pull up the meeting minutes from the steering divisions to see what they’ve been doing. If steering divisions went away, who would be responsible for those things.
  • Discussion Topics
    • Management group health metrics
  • notional division of products into product families and lines, to provide examples for peer review.
    • Level of granularity
    • Identify which pieces are orphaned, and the political elements to be surfaced.
    • Positioning cross-product family artifacts (standards naming)
  • BAM-lite feedback and review
    • Governance on V2.x (v2.9 substantive changes)
    • develop form to request establishing a Product Family

Minutes

Convened

Adjourned

Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items

© 2018 Health Level Seven® International. All rights reserved